99
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES Cellular and Molecular Biology

Overexpression of a New Gene p28GANK Confers Multidrug Resistance of Gastric Cancer Cells

, , , , , & show all
Pages 129-139 | Published online: 11 Jun 2009
 

Abstract

Here we investigated the roles of P28GANK in multidrug resistance of gastric cancer cells and the possible mechanisms. We constructed the siRNA vector of P28GANK and transfected it into human vincristine-resistant gastric adenocarcinoma cell line SGC7901/VCR. Down-regulation of P28GANK could enhance the sensitivity of SGC7901/VCR cells towards anticancer drugs and could decrease the capacity of cells to efflux adriamycin. P28GANK could down-regulate the expression of P-gp, but not affect MRP or GST. In vivo experiment also confirmed our above results. Further study of the biological functions of P28GANK might be helpful for understanding the mechanisms of MDR in gastric cancer.

ABBREVIATIONS
VCR=

vincristine

ADR=

adriamycin

5-Flu=

5-fluorouracil

CDDP=

cisplatin

MTT=

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

PBS=

phosphate buffered saline

MDR=

multidrug resistance

P-gp=

P-glycoprotein

ABBREVIATIONS
VCR=

vincristine

ADR=

adriamycin

5-Flu=

5-fluorouracil

CDDP=

cisplatin

MTT=

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

PBS=

phosphate buffered saline

MDR=

multidrug resistance

P-gp=

P-glycoprotein

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.